Publicaciones (80) Publicaciones en las que ha participado algún/a investigador/a

2018

  1. A 60-Year-Old Male Smoker With Chronic Obstructive Pulmonary Disease and Hypereosinophilia

    Archivos de Bronconeumologia, Vol. 54, Núm. 7, pp. 394-395

  2. A new approach to treat joint injuries: Combination of intra-articular and intraosseous injections of platelet rich plasma

    Platelet Rich Plasma in Orthopaedics and Sports Medicine (Springer International Publishing), pp. 145-161

  3. A phase ii multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy

    Haematologica, Vol. 103, Núm. 8, pp. 1351-1358

  4. Allogeneic mesenchymal stem cells and biomaterials: The perfect match for cardiac repair?

    International Journal of Molecular Sciences, Vol. 19, Núm. 10

  5. An Inducible Promoter Responsive to Different Porphyrinogenic Stimuli Improves Gene Therapy Vectors for Acute Intermittent Porphyria

    Human Gene Therapy, Vol. 29, Núm. 4, pp. 480-491

  6. An rna toolbox for cancer immunotherapy

    Nature Reviews Drug Discovery, Vol. 17, Núm. 10, pp. 751-767

  7. Anti-PD1 associated fulminant myocarditis after a single pembrolizumab dose: The role of occult pre-existing autoimmunity

    Haematologica

  8. Aterosclerosis y hematopoyesis clonal: un nuevo factor de riesgo

    Clínica e investigación en arteriosclerosis, Vol. 30, Núm. 3, pp. 133-136

  9. Atherosclerosis and clonal hematopoyesis: A new risk factor

    Clinica e Investigacion en Arteriosclerosis, Vol. 30, Núm. 3, pp. 133-136

  10. Autologous bioscaffolds based on different concentrations of platelet rich plasma and synovial fluid as a vehicle for mesenchymal stem cells

    Journal of Biomedical Materials Research - Part A, Vol. 106, Núm. 2, pp. 377-385

  11. Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia

    Leukemia, Vol. 32, Núm. 4, pp. 874-881

  12. BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee

    Biology of Blood and Marrow Transplantation, Vol. 24, Núm. 4, pp. 641-648

  13. Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1326-1334

  14. Bioengineered PBGD variant improves the therapeutic index of gene therapy vectors for acute intermittent porphyria

    Human Molecular Genetics, Vol. 27, Núm. 21, pp. 3688-3696

  15. Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases

    Leukemia, Vol. 32, Núm. 11, pp. 2512-2518

  16. Bmi1-progenitor cell ablation impairs the angiogenic response to myocardial infarction

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 38, Núm. 9, pp. 2160-2173

  17. COBRA methods and metabolic drug targets in cancer

    Molecular and Cellular Oncology, Vol. 5, Núm. 1

  18. CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I

    Nature Communications, Vol. 9, Núm. 1

  19. Cancer-associated thrombosis: Beyond clinical practice guidelines-A multidisciplinary (SEMI-SEOM-SETH) expert consensus

    TH Open, Vol. 2, Núm. 4, pp. e373-e386

  20. Causes of Death in Patients with Venous Thromboembolism Anticoagulated with Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis

    Seminars in Thrombosis and Hemostasis, Vol. 44, Núm. 4, pp. 377-387